Sano has created a data-sharing platform that allows anyone to contribute their medical and genetic data in order to be matched with clinical research. To speed up genetic illness research, the company also provides free genomic sequencing and analysis to those who participate in its associated research programs.
The Cambridge-based genetics startup has doubled its revenue every six months since its inception in 2017 and forged strong partnerships with the top genetic biobanks in the UK and Australia, as well as patient groups.
This growth led to a recent $11 million Series A round led by MMC Ventures, with participation from Episode 1, Seedcamp, and angels including Paul Forster, co-founder and ex-CEO of Indeed, former VP of innovation at PatientsLikeMe Paul Wicks, and former CEO of Ancestry.com Margo Georgiadis.
2022 • Series A
Sano Genetics is a personalised medicine research platform, with a focus on data privacy and transparency. Their user-centric genetic data marketplace connects individuals directly to the research world, acting as ethical brokers to facilitate a direct connection between patients and research institutions.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!